Table 2.

Antibodies against the HOD antigen are able to induce AMIS independent of their ability to induce RBC clearance but related to their capacity to promote RBC antigen and membrane loss

 
 

AMIS: the degree to which each antibody inhibited the HEL-specific IgM response 7 days after HOD-RBC transfusion and expressed as percent inhibition of alloimmunization (–, <20%; +, 20%-49%; ++, 50%-69%; +++, 70%-89%; and ++++, >90%).

RBC clearance: the degree to which HOD-specific antibodies induced HOD-RBC clearance from the circulation in the recipient mouse. This was calculated based on the percentage of transfused PKH26+HOD-RBCs remaining in circulation in the recipient mouse in comparison with before antibody injection (–, <25%; +, 25%-35%; ++, 36%-49%; +++, 50%-69%; and ++++, >70%).

Antigen loss: the degree to which the antibody induced loss of the epitope from HOD-RBCs recovered from recipient mice 24 hours after antibody injection. This was calculated based on the percentage of antigen remaining on recovered HOD-RBCs (–, <5%; +, 5%-24%; ++, 25%-49%; +++, 50%-69%; and ++++, >70%).

RBC membrane loss: the degree to which the antibody induced loss of PKH26 membrane fluorescence from HOD-RBCs recovered 24 hours after antibody injection. Expressed as the percentage of membrane fluorescence lost (–, <2.4%; +, 2.5%-24%; ++, 25%-49%; +++, 50%-69%; and ++++, >70%).

N/T: not tested.

∗Symbols for each experimental group are explained in Figure 2.

†The results are shown in supplemental Figure 4.

‡The results are shown in supplemental Figure 5.

or Create an Account

Close Modal
Close Modal